A critical advance in cancer study is occurring with the use of VHH fragments to restore mutated p53. This vital cancer inhibitor protein is frequently disabled in various forms of cancer, leading uncontrolled body https://social-medialink.com/story7014951/mini-antibodies-restore-tumor-suppressor-p53-new-new-pathway-for-malignant-treatment